SARS-COV-2 SPIKE (AA 251-660) RECOMB

General description

SARS-CoV-2 Spike (aa 251-660) Recombinant Antigen expressed in E. coli, Cat. No. AGX821 is for use in ELISA and Lateral Flow Assay.

Immunogen

fragment

Application

Alternative antigen recommendations are AGX822, AGX823, or AGX824

Target description

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the virus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. A SARS-CoV-2 spike antigen can be used to support the detection of SARS-CoV-2 (COVID-19, 2019-nCoV).

Physical form

Purified protein in 20mM Citrate buffer without preservatives, pH 9.5.

Reconstitution

Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.

Storage and Stability

Stable for 1 year at -20°C from date of receipt. Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.